Heron Therapeutics, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for HRTX, updated each market day.
HRTX AI Sentiment
AI predicts Heron Therapeutics, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Heron Therapeutics, Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Sector
Exchange
Market Cap
$154,487,329
Cap Tier
Employees
122
Headquarters
SAN DIEGO, CA
Listed Since
Aug. 27, 1987
Website
HRTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
HRTX Volatility
Heron Therapeutics, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
